Prochlorperazine maleate and Sunitinib malate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prochlorperazine maleate (prochlorperazine maleate) and Sunitinib malate (sunitinib malate). Common drug interactions include constipation among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Prochlorperazine maleate and Sunitinib malate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Prochlorperazine maleate?

Prochlorperazine maleate has active ingredients of prochlorperazine maleate. It is often used in nausea. eHealthMe is studying from 10,027 Prochlorperazine maleate users. Check the latest studies of Prochlorperazine maleate.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

On Jul, 21, 2026

13 people who take Prochlorperazine maleate and Sunitinib malate together, and have interactions are studied.

Prochlorperazine maleate and Sunitinib malate drug interactions.

What are the common drug interactions of Prochlorperazine Maleate and Sunitinib Malate, by gender? *:

female:

Constipation
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Metastases to liver (cancer spreads to liver)
Peripheral swelling
Skin exfoliation (removal of the oldest dead skin cells)
Skin ulcer
Sleep disorder
Weight fluctuation
Disease progression

male:

Renal failure acute (rapid kidney dysfunction)
Disease progression
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Impaired healing
Laryngeal oedema (swelling of larynx)
Renal cell carcinoma stage iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes)
Renal failure (kidney dysfunction)
Skin ulcer

What are the common drug interactions of Prochlorperazine Maleate and Sunitinib Malate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Laryngeal oedema (swelling of larynx)

50-59:

Renal failure acute (rapid kidney dysfunction)
Disease progression
Blood cholesterol increased
Blood thyroid stimulating hormone increased
Constipation
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Metastases to liver (cancer spreads to liver)
Neuroendocrine tumour (a tumour that forms from cells that release hormones into the blood in response to a signal from the nervous system)
Peripheral swelling

60+:

Back pain
Blood cholesterol increased
Dizziness
Dry mouth
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Foot deformity (functional disability of foot)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Heart rate increased

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 10 people, 76.92%
Stress And Anxiety: 5 people, 38.46%
Nausea And Vomiting: 5 people, 38.46%
Muscle Spasms (muscle contraction): 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 15.38%
Pain: 2 people, 15.38%
Hepatic Neoplasm Malignant Non-Resectable (liver cancer non-resectable): 1 person, 7.69%
Constipation: 1 person, 7.69%
Cough: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Prochlorperazine maleate and Sunitinib malate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously